Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 1
1995 1
1998 1
2005 1
2006 1
2008 1
2013 1
2014 2
2015 4
2016 3
2017 2
2018 3
2020 4
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS).
Lenders M, Nordbeck P, Kurschat C, Karabul N, Kaufeld J, Hennermann JB, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das AM, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, Stumpfe K, Blaschke D, Brand SM, Mann WA, Kampmann C, Muschol N, Canaan-Kühl S, Brand E. Lenders M, et al. Among authors: canaan kuhl s. Clin Pharmacol Ther. 2020 Aug;108(2):326-337. doi: 10.1002/cpt.1832. Epub 2020 Apr 27. Clin Pharmacol Ther. 2020. PMID: 32198894
Treatment of fabry disease with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
Lenders M, Nordbeck P, Kurschat C, Eveslage M, Karabul N, Kaufeld J, Hennermann JB, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das AM, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, von Cossel K, Blaschke D, Brand SM, Alexander Mann W, Kampmann C, Muschol N, Canaan-Kühl S, Brand E. Lenders M, et al. Among authors: canaan kuhl s. Eur Heart J Cardiovasc Pharmacother. 2021 Mar 16:pvab025. doi: 10.1093/ehjcvp/pvab025. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33725118
[Pain therapy for Fabry's disease].
Sommer C, Uçeyler N, Duning T, Arning K, Baron R, Brand E, Canaan-Kühl S, Hilz M, Naleschinski D, Wanner C, Weidemann F. Sommer C, et al. Among authors: canaan kuhl s. Internist (Berl). 2013 Jan;54(1):121-2, 124-30. doi: 10.1007/s00108-012-3204-5. Internist (Berl). 2013. PMID: 23250563 Review. German.
Treatment switch in Fabry disease- a matter of dose?
Lenders M, Nordbeck P, Canaan-Kühl S, Kreul L, Duning T, Lorenz L, Pogoda C, Brand SM, Wanner C, Brand E. Lenders M, et al. Among authors: canaan kuhl s. J Med Genet. 2021 May;58(5):342-350. doi: 10.1136/jmedgenet-2020-106874. Epub 2020 Jun 10. J Med Genet. 2021. PMID: 32522756
Bridging the Gap Between Vessels and Nerves in Fabry Disease.
Forstenpointner J, Sendel M, Moeller P, Reimer M, Canaan-Kühl S, Gaedeke J, Rehm S, Hüllemann P, Gierthmühlen J, Baron R. Forstenpointner J, et al. Among authors: canaan kuhl s. Front Neurosci. 2020 Jun 16;14:448. doi: 10.3389/fnins.2020.00448. eCollection 2020. Front Neurosci. 2020. PMID: 32612493 Free PMC article.
Late-onset Bartter syndrome type II.
Gollasch B, Anistan YM, Canaan-Kühl S, Gollasch M. Gollasch B, et al. Among authors: canaan kuhl s. Clin Kidney J. 2017 Oct;10(5):594-599. doi: 10.1093/ckj/sfx033. Epub 2017 May 8. Clin Kidney J. 2017. PMID: 28979772 Free PMC article.
The natriuretic peptides and their receptors.
Jamison RL, Canaan-Kühl S, Pratt R. Jamison RL, et al. Among authors: canaan kuhl s. Am J Kidney Dis. 1992 Nov;20(5):519-30. doi: 10.1016/s0272-6386(12)70269-x. Am J Kidney Dis. 1992. PMID: 1442767 Review.
Long-term Outcomes of Kidney Transplantation in Fabry Disease.
Ersözlü S, Desnick RJ, Huynh-Do U, Canaan-Kühl S, Barbey F, Genitsch V, Mueller TF, Cheetham M, Flammer AJ, Schaub S, Nowak A. Ersözlü S, et al. Among authors: canaan kuhl s. Transplantation. 2018 Nov;102(11):1924-1933. doi: 10.1097/TP.0000000000002252. Transplantation. 2018. PMID: 29688992 Free article.
29 results